ACCUSTEM SCIENCES, INC. (ACUT)

Every figure this model derived for ACUT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2022-12-31
current assets 106,204 AssetsCurrent 2026-06-30
current liabilities 5,723,821 LiabilitiesCurrent 2026-06-30
equity -4,117,617 StockholdersEquity 2026-06-30
interest expense 1,734 InterestPaidNet 2026-06-30
ocf -1,204,800 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 98,400 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 69,811 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up ACUT on one particular measure came for.

RatioValue
cash operating margin-1608.24
current ratio0.02
current ratio reported0.02
dilution pct33.24
fcf margin-1224.39
interest cover-953.14
operating margin-1679.61
owner earnings margin-1295.34
sbc pct revenue70.95

What to be careful about

What this model itself distrusts about ACUT's figures. Written by the derivation as it ran, not added afterwards.